Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6284804 | SANDOZ | Topical suspension formulations containing ciprofloxacin and dexamethasone |
Aug, 2020
(3 years ago) | |
US6359016 | SANDOZ | Topical suspension formulations containing ciprofloxacin and dexamethasone |
Aug, 2020
(3 years ago) | |
US9402805 | SANDOZ | Method of treating middle ear infections |
Sep, 2022
(1 year, 7 months ago) | |
US9149486 | SANDOZ | Method of treating middle ear infections |
Sep, 2022
(1 year, 7 months ago) | |
US9345714 | SANDOZ | Method of treating middle ear infections |
Sep, 2022
(1 year, 7 months ago) | |
US8846650 | SANDOZ | Method of treating middle ear infections |
Jun, 2025
(1 year, 1 month from now) |
Market Authorisation Date: 18 July, 2003
Treatment: Treatment of acute otitis externa; Treatment of acute otitis media
Dosage: SUSPENSION/DROPS;OTIC